Funding Details
- Awarder
- Inbox
- Date Award
- April 28, 2020
- Vertical
- Biopharma
- Funding URL
- View Funding Page
- Funding Amount:
-
$210,500,000
Company Info
- Founders
- Dr. A. Bruce Montgomery
- Company Description
- Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.
- Market
- Idiopathic pulmonary fibrosis (IPF) and severe respiratory diseases
- Location
-
Seattle,
WA,
USA
- Coinvestors
- F-Prime Capital Partners, Norwest Venture Partners, Novo Holdings, Pivotal bioVenture Partners, RiverVest Venture Partners, TPG Biotech, Catalio Capital Management, Eventide Asset Management, Perceptive, Xontogeny Venture Fund, Piper Heartland Healthcare Capital, Rock Springs Capital, SR One, Surveyor Capital, T. Rowe Price Associates, Vida Ventures, Wellington Management
Links